| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/08/1996 | WO1996003428A1 Antiprotozoal cyclic tetrapeptides |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | WO1996003048A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | WO1995033851A3 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4418936A1 Polypeptid Polypeptide |
| 02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | CA2195969A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195804A1 Novel topoisomerase iv, corresponding nucleotide sequences and uses thereof |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195786A1 Isoamylase gene from flaviobacterium sp., compositions containing it andmethods using it |
| 02/08/1996 | CA2195669A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | CA2194999A1 Antiprotozoal cyclic tetrapeptides |
| 02/08/1996 | CA2194683A1 Process for demethylating s-methyl-mercapto compounds |
| 02/08/1996 | CA2194578A1 New process for the production of biologically active protein |
| 02/08/1996 | CA2193851A1 Purified herpes simplex virus protease and methods of purification |
| 02/07/1996 | EP0695804A2 Recombinant enzyme for converting maltose into trehalose |
| 02/07/1996 | EP0695803A2 Epitopic regions of pneumococcal surface protein A |
| 02/07/1996 | EP0695801A2 Yeast protein derived peptide compositions, a process for preparing them and their use |
| 02/07/1996 | EP0695361A1 Expression of heterologous genes according to a targeted expression profile |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695358A1 Recombinant antigens from mumps virus and their use in vaccines |
| 02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |
| 02/07/1996 | EP0695356A1 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
| 02/07/1996 | EP0695350A1 Process for purifying collagenase |
| 02/07/1996 | EP0695348A1 Lipase variants |
| 02/07/1996 | EP0695347A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 02/07/1996 | EP0695345A1 MICROORGANISM OF GENUS -i(BACILLUS CEREUS) AND USE THEREOF |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/06/1996 | US5489743 Transgenic animal models for thrombocytopenia |
| 02/06/1996 | US5489562 Herbicide comprising acivicin and α-methyl derivatives thereof |
| 02/06/1996 | US5489530 Active at ph 3.5-9.0 and not inhibited by sodium deoxycholate; used for producing drugs for therapy of maldigestion |
| 02/06/1996 | US5489528 Recombinant core-streptavidin |
| 02/06/1996 | US5489527 Translation of m-RNA |
| 02/06/1996 | US5489521 Biologically pure culture of pseudomonas syringae |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489513 Specific gene probes and processes for the diagnostic investigation of Candida albicans |
| 02/06/1996 | US5489432 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 02/06/1996 | CA2073622C Composition derived from a succinoglucane, its preparation process and its applications |
| 02/06/1996 | CA2056437C Production of virus and purification of viral envelope proteins for vaccine use |
| 02/06/1996 | CA2048055C Composition containing a polysaccharide obtained by microbial fermentation |
| 02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/01/1996 | WO1996002661A1 Process for producing protein capable of molecular weight reduction caused by protease of host-cell origin |
| 02/01/1996 | WO1996002657A1 Microbial method |
| 02/01/1996 | WO1996002656A1 Taxane production in haploid-derived cell cultures |
| 02/01/1996 | WO1996002653A1 Thermophilic fungal expression system |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002638A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 02/01/1996 | WO1996002635A1 Enzyme from microbial source: phthalyl amidase |
| 02/01/1996 | WO1996002634A1 Active calpain expressed by baculovirus |
| 02/01/1996 | WO1996002633A1 Novel acid-stable and thermo-stable enzymes derived from sulfolobus species |
| 02/01/1996 | WO1996002632A1 Novel xylanase, process for producing the same, method for the treatment of pulp, and production of xylo-oligosaccharides |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002567A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | WO1996002562A1 Process for the purification of basic fibroblast growth factor |
| 02/01/1996 | WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | WO1996002141A1 A method of improving the quality of plant seeds |
| 02/01/1996 | WO1995034655A3 Surface protein of staphylococcus aureus |
| 02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | CA2195022A1 Novel acid-stable and thermo-stable enzymes derived from sulfolobus species |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194861A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | CA2194769A1 Enzyme from microbial source: phthalyl amidase |
| 02/01/1996 | CA2194763A1 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 02/01/1996 | CA2194701A1 Taxane production in haploid-derived cell cultures |
| 02/01/1996 | CA2192681A1 Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 01/31/1996 | EP0694616A2 Process for the preparation of hyaluronic acid by fermentation with streptococcus |
| 01/31/1996 | EP0694614A1 Process for producing L-amino acid |
| 01/31/1996 | EP0694611A2 Cozynebacterium sp. J1, method for biodegradation of aromatic compounds and/or chlorinated organic compounds, and method for environmental remediation using it |
| 01/31/1996 | EP0694610A1 COATED $i(PHAFFIA RHODOZYMA) YEAST AND GRANULE THEREOF |
| 01/31/1996 | EP0694560A2 Production of antigens of Pasteurella |
| 01/31/1996 | EP0694309A2 Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection |
| 01/31/1996 | EP0694081A1 RECOMBINANT $g(a)-N-ACETYLGALACTOSAMINIDASE ENZYME AND cDNA ENCODING SAID ENZYME |
| 01/31/1996 | EP0694075A1 Thermostable dna topoisomerase v |
| 01/31/1996 | EP0694074A1 Production of plastics materials from microorganisms |
| 01/31/1996 | EP0694073A1 Improved fat splitting process |
| 01/31/1996 | EP0694072A1 Transposition assembly for gene transfer in eukaryotes |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694069A1 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
| 01/31/1996 | EP0694068A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 01/31/1996 | EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 01/31/1996 | EP0694065A1 Protease variants |
| 01/31/1996 | EP0694064A1 A METHOD OF HYDROLYSING CHOLESTEROL ESTERS BY USING A $i(PSEUDOMONAS FRAGI) CHOLESTEROL ESTERASE |
| 01/31/1996 | EP0694063A1 An amylolytic enzyme |
| 01/31/1996 | EP0694062A1 New bacillus thuringiensis strains and their insecticidal proteins |
| 01/31/1996 | EP0694044A1 Method and product for regulating cell responsiveness to external signals |
| 01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
| 01/31/1996 | EP0693935A1 Method and compositions for digesting tissue |